Acceleration of Iron Utilization After Intravenous Iron Administration During Activated Erythropoiesis in Hemodialysis Patients: A Randomized Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1744-9987|19|2|131-137

ISSN： 1744-9979

Source： THERAPEUTIC APHERESIS AND DIALYSIS, Vol.19, Iss.2, 2015-04, pp. : 131-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Oxidative Stress following Intravenous Iron Injection in Patients on Chronic Hemodialysis: A Comparison of Iron-Sucrose and Iron-Dextran

By  

Nephron Clin Pract, Vol. 118, Iss. 3, 2010-12 ,pp. : c249-c256

Karger

Access to resources Recommend Favorite

Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients with Cancer- or Chemotherapy-Induced Anemia

By  

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 45-49

Karger

Access to resources Recommend Favorite

Effects of Intravenous Polymaltose Iron on Oxidant Stress and Non-Transferrin-Bound Iron in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 99, Iss. 3, 2005-01 ,pp. : c63-c67

Karger

Access to resources Recommend Favorite

Safety and Usefulness of Intravenous Iron Sucrose in the Management of Preoperative Anemia in Patients with Menorrhagia: A Phase IV, Open-Label, Prospective, Randomized Study

By  

Acta Haematologica, Vol. 121, Iss. 1, 2009-03 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

Costs Associated with Erythropoiesis-Stimulating Agent Administration to Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 106, Iss. 4, 2007-06 ,pp. : c193-c198

Karger

Access to resources Recommend Favorite